Financials
- Market Capitalization 1.81 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.67
市销率
31.2
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2067 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.41 USD | -0.42% | +23.69% | +50.76% | +53.15% | 1.82 B USD | ||
| 2070 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.56 USD | -3.64% | -7.33% | -5.60% | +91.72% | 1.81 B USD | ||
| 2085 | SEPN Septerna, Inc. - Common Stock | 37.97 USD | -2.42% | -5.73% | +10.22% | +72.51% | 1.77 B USD | ||
| 2094 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.68 USD | -1.48% | +1.85% | +19.74% | -7.58% | 1.78 B USD |